Talk:Brigatinib
Latest comment: 7 years ago by Rod57 in topic Could add a section Clinical trials
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Brigatinib.
|
Related
editCurrently there are no papers on this compound, only patents, however the following paper maybe related doi:10.1073/pnas.1019559108 --Project Osprey (talk) 16:18, 23 January 2015 (UTC)
Could add a section Clinical trials
editto summarise at least the trials that led to the orphan drug status and the accelerated approval ? - Rod57 (talk) 10:48, 29 July 2017 (UTC)